24 month PANGAEA: a 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice

被引：0
|
作者：
Ziemssen, T. [1 ]
Fuchs, A. [2 ]
Schwarz, H-J [3 ]
van Lokven, T. [2 ]
Cornelissen, C. [2 ]
机构：
[1] Karl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Kantar Hlth, Munich, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P107
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [31] THE ANTIDEPRESSANT EFFICACY OF AGOMELATINE IN DAILY PRACTICE: RESULTS OF THE NON-INTERVENTIONAL STUDY VIVALDI
    Laux, G.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [32] Efficacy and tolerability of glimepiride in daily practice - A non-interventional observational cohort study
    Scholz, GH
    Schneider, K
    Knirsch, W
    Becker, G
    CLINICAL DRUG INVESTIGATION, 2001, 21 (09) : 597 - 604
  • [33] Development of former fingolimod study patients in a real world setting: results from the 4 year interim analysis of the non-interventional trial PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 643 - 644
  • [34] Safety of treatment with biologics for psoriasis in daily practice: 5-year data
    PPM Van Lümig
    RJB Driessen
    MAM Berends
    J B Boezeman
    PCM van de Kerkhof
    EMGJ de Jong
    Journal of Translational Medicine, 8 (Suppl 1)
  • [35] Safety of treatment with biologics for psoriasis in daily practice: 5-year data
    van Lumig, P. P. M.
    Driessen, R. J. B.
    Berends, M. A. M.
    Boezeman, J. B. M.
    van de Kerkhof, P. C. M.
    de Jong, E. M. G. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (03) : 283 - 291
  • [36] Study design and first results of a non-interventional registry study to establish long-term safety and pharmaco-economic data on fingolimod (Gilenya®) in multiple sclerosis patients in Germany (PANGAEA)
    Ziemssen, T.
    van Lokven, T.
    Kempcke, R.
    Meergans, M.
    JOURNAL OF NEUROLOGY, 2012, 259 : S72 - S72
  • [37] Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)
    Ziemssen, Tjalf
    van Lokven, Tom
    Kempke, Raimar
    Meergans, Matthias
    NEUROLOGY, 2012, 78
  • [38] A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients
    Ulf W Tunn
    BMC Urology, 11
  • [39] A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients
    Tunn, Ulf W.
    BMC UROLOGY, 2011, 11
  • [40] The antidepressant efficacy of agomelatine in daily practice : interim-analysis of the non-interventional study VIVALDI
    Laux, G.
    Steinmann, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 77 - 77
12345